Bicycle Therapeutics Tech Stack

Bicycle Therapeutics uses 8 technology products and services including Unpkg, WordPress, Cloudflare, and more. Explore Bicycle Therapeutics's tech stack below.

  • Unpkg
    Content Delivery Network
  • WordPress
    Content Management System
  • Cloudflare
    Content Management System
  • Font Awesome
    Font Scripts
  • AngularJS
    Javascript Frameworks
  • Underscore.js
    Javascript Libraries
  • Draftpress HFCM
    Web Platform Extensions
  • Twitter
    Widgets

Media & News

Bicycle Therapeutics's Email Address Formats

Bicycle Therapeutics uses at least 4 format(s):
Bicycle Therapeutics Email FormatsExamplePercentage
firlast@bicycletherapeutics.comJohDoe@bicycletherapeutics.com
50%
firstlast@bicycletherapeutics.comJohnDoe@bicycletherapeutics.com
17%
first.middle@bicycletherapeutics.comJohn.Michael@bicycletherapeutics.com
16%
firstlas@bicycletherapeutics.comJohnDoe@bicycletherapeutics.com
17%

Frequently Asked Questions

Where is Bicycle Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Bicycle Therapeutics's main headquarters is located at Granta Park Cambridge, England CB21 6GP GB. The company has employees across 3 continents, including EuropeNorth AmericaOceania.

What is Bicycle Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Bicycle Therapeutics's main corporate office by phone at +44-1223-497415. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Bicycle Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Bicycle Therapeutics is a publicly traded company; the company's stock symbol is BCYC.

What is Bicycle Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Bicycle Therapeutics's official website is bicycletherapeutics.com and has social profiles on LinkedIn.

How much revenue does Bicycle Therapeutics generate?

Minus sign iconPlus sign icon
As of February 2024, Bicycle Therapeutics's annual revenue reached $75M.

What is Bicycle Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Bicycle Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Bicycle Therapeutics have currently?

Minus sign iconPlus sign icon
As of February 2024, Bicycle Therapeutics has approximately 270 employees across 3 continents, including EuropeNorth AmericaOceania. Key team members include Chief Executive Officer: K. L.Chief Scientific Officer: N. K.Chief Operating Officer: A. M.. Explore Bicycle Therapeutics's employee directory with LeadIQ.

What industry does Bicycle Therapeutics belong to?

Minus sign iconPlus sign icon
Bicycle Therapeutics operates in the Biotechnology Research industry.

What technology does Bicycle Therapeutics use?

Minus sign iconPlus sign icon
Bicycle Therapeutics's tech stack includes UnpkgWordPressCloudflareFont AwesomeAngularJSUnderscore.jsDraftpress HFCMTwitter.

What is Bicycle Therapeutics's email format?

Minus sign iconPlus sign icon
Bicycle Therapeutics's email format typically follows the pattern of firlast@bicycletherapeutics.com. Find more Bicycle Therapeutics email formats with LeadIQ.

How much funding has Bicycle Therapeutics raised to date?

Minus sign iconPlus sign icon
As of February 2024, Bicycle Therapeutics has raised $200M in funding. The last funding round occurred on Jun 12, 2023.

When was Bicycle Therapeutics founded?

Minus sign iconPlus sign icon
Bicycle Therapeutics was founded in 2009.
Bicycle Therapeutics

Bicycle Therapeutics

Biotechnology ResearchEngland, United Kingdom201-500 Employees

Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. 

Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTC™) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICA™ targeting Nectin-4 and agonizing CD137, in company-sponsored Phase I/II trials. In addition, BT1718, a BTC that targets MT1-MMP, is being investigated in an ongoing Phase I/IIa clinical trial sponsored by the Cancer Research UK Centre for Drug Development. 

Bicycle is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Cambridge, MA. For more information, visit bicycletherapeutics.com.

Section iconCompany Overview

Headquarters
Granta Park Cambridge, England CB21 6GP GB
Phone number
+44-1223-497415
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BCYC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
201-500

Section iconFunding & Financials

  • $200M

    Bicycle Therapeutics has raised a total of $200M of funding over 13 rounds. Their latest funding round was raised on Jun 12, 2023.

  • $50M$100M

    Bicycle Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $200M

    Bicycle Therapeutics has raised a total of $200M of funding over 13 rounds. Their latest funding round was raised on Jun 12, 2023.

  • $50M$100M

    Bicycle Therapeutics's revenue is in the range of $50M$100M

© LeadIQ, Inc. All rights reserved.